AAV-hmAb

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAAV-hmAb
Drug Alias NameAAV-hmAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMicrotubule-associated protein tau modulatorsImmunomodulators
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsNeurodegenerative DiseasesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurimmune Ag
China Registration ClassN/A

Develop Information

Active CompaniesNeurimmune Ag
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A